CASI PHARMACEUTICALS INC (CASI)

KYG1933S1012 - Common Stock

2.25  +0.01 (+0.45%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
33.88M43.11M30.17M15.14M4.13M
Minority Interest Expense
2.60M8.74M700.00K920.00K400.00K
Cost Of Goods
13.83M15.83M12.56M9.51M3.94M
Gross Profit
20.05M27.28M17.61M5.63M200.00K
Operating Expenses
45.33M53.77M52.89M38.95M40.18M
Research and Development
9.86M16.00M14.42M11.47M9.75M
Selling, General, and Administrative Expenses
41.84M37.78M38.47M27.48M30.44M
Operating Income
-25.28M-26.49M-35.28M-33.32M-39.99M
Interest Income/Expense
233.00K-200.00K6.30M3.93M1.59M
Other Income/Expense
764.00K40.00K560.00K80.00K10.00K
Non Recurring Items
-2.01M-10.78M-7.42M-18.21M-6.97M
Income Before Taxes
-26.29M-37.43M-35.84M-47.51M-45.36M
Income Tax
-81.00K1.98M0.00N/AN/A
Net Income
-26.96M-41.01M-36.65M-48.29M-46.03M
EBITDA
-21.54M-24.07M-33.46M-31.36M-37.84M
 
Per Share Data
EPS Diluted Total Ops
-2.02-3.01-2.69-4.37-4.80
Non GAAP EPS
-2.02-3.40-2.70-4.20-4.70
 
Statistics
Gross Profit Margin
59.19%63.28%58.37%37.19%4.84%
Profit Margin
-79.58%-95.13%-121.48%-318.96%-1114.53%
Operating Profit Margin
-74.62%-61.45%-116.94%-220.08%-968.28%

All data in USD

Charts